Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FHN33
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,547
Award facts
- Contract value 100% obligated
- $10,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,547.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs, enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains. The award involved no set-aside designation and was competitively awarded through firm fixed pricing. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of June 20, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements, ranging from specialty medications and diabetes treatments to neurological pharmaceuticals and medical devices. This delivery order for Zepbound, a diabetes medication, exemplifies AmerisourceBergen's role in supporting military and veteran healthcare supply chains through DLA's pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DB25FHN33?
SPE2DB25FHN33 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FHN33 worth?
The government has obligated $10,547 on SPE2DB25FHN33.
Is contract SPE2DB25FHN33 an order under another contract?
Yes. SPE2DB25FHN33 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHN33 competed?
The extent of competition for SPE2DB25FHN33 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award